Mills & Reeve | Life sciences reposted this
Read our latest newsletter here: https://lnkd.in/eeeznPX4
Mills & Reeve | Life sciences
Legal Services
Our life sciences lawyers can help you make the most of your ideas and products, offering all the legal advice you need.
About us
The industry is innovative but also highly complex. Our life sciences lawyers can help you make the most of your ideas and products, offering all the legal advice you need. Our experience is extensive and includes: - Supporting a speciality pharmaceuticals group on the development and commercialisation of its lead drug candidates – putting in place a suite of supply chain and market access agreements, a Phase III clinical trial programme and setting up EU operations. - Advising a Swiss-based biotech business on a range of technology in-licensing transactions. - Supporting a Danish global pharma group on UK product compliance issues. - Advising on a large number of fundraisings, including IPOs, for a number of pharma, device, diagnostic and digital health organisations. - Providing strategic HR support to international pharma businesses. - Supporting o2h on the creation of early stage EIS and SEIS investment funds to back biotech therapeutic opportunities. - Helping a global pharma business with data compliance issues around a clinical trial. - Advising IQ Capital on its follow-on investment in Fluidic Analytics, as part of a £21million fundraising. - Helping Autolus relocate to the former BBC base at White City. - Advising the Sanger Institute on strategic research collaborations with industry partners.
- Website
-
https://www.mills-reeve.com/sectors/life-sciences
External link for Mills & Reeve | Life sciences
- Industry
- Legal Services
- Company size
- 1,001-5,000 employees
Updates
-
Read our latest newsletter here: https://lnkd.in/eeeznPX4
-
-
Thoughts from Steph Caird on how to enable patients to find clinical trials that could benefit them. https://lnkd.in/eAaFY6jy #clinicaltrials #womenshealth
-
-
Unexpected increases in the payment rates under both the VPAG scheme and statutory scheme will make planning difficult for pharma companies operating in the UK. Isabel Teare and Hugh Thompson explain. https://lnkd.in/ekyq4bnj
-
We looked at the impact of the Digital Markets, Competition and Consumers Act 2024 (the DMCC Act) on the life sciences sector when the legislation was passed. Consumer-facing products and services will need to take account of new rules particularly for · subscription contracts · drip pricing · fake reviews You can read more about that here https://lnkd.in/e77EpjgN. Jason Freeman, director for consumer law at the CMA, provides a helpful explainer on how these rules will be enforced. https://lnkd.in/eFc7zPe9 #consumerlaw #healthtech Katrina Anderson Isabel Teare Steph Caird
-
-
An innovative regulatory framework for cell and gene therapies and other point-of-care approaches to treating patients. #celltherapy #genetherapy #ATMP Hugh Thompson https://lnkd.in/eyXkWH9M
-
-
As the shake-up across US Federal Government continues we look at the possible impact on healthcare for women and their inclusion in clinical research #womenshealth #clinicaltrials Isabel Teare Tania Richards https://lnkd.in/ecDRuVYG
-
The UK's clinical trials regime is seeing a refresh, with changes to enhance efficiency and provide a more flexible approach. #clinicaltrials #medicines #pharmaceuticals https://lnkd.in/ebBC_m9m
-
-
We take a look at progress on the UK's #medicaldevice #regulatory reform package, and there's an opportunity to feed into the latest consultation. https://lnkd.in/eF8FrncJ Steph Caird Isabel Teare
-
-
The ABPI Code regulating the promotion of pharmaceuticals has been updated, along with the procedural framework for addressing complaints. Hugh Thompson and Isabel Teare review the changes. https://lnkd.in/etdxR-aX #medicines #pharmaceuticals #advertising
-